Writing your favorite psychedelics newsletter. 🫠
[5-min read] Q&A with Sher Butt, Cofounder & CEO
[3-min read] Facilitators speak on using psychedelics to process a life-threatening diagnosis.
[5-min read] New study explores trauma recall during psychedelic experiences and extended difficulties.
[5-min read] Q&A with William Leonard Pickard, Chemist & Advisor
[3-min read] Facilitators advise on selecting the right psilocybin mushroom strain for microdosing.
[5-min read] Reunion Neuroscience shares results from Phase 2 postpartum depression trial.
[6-min read] Q&A with Hanifa Nayo Washington, Healing Justice Practitioner
[3-min read] Facilitators describe the optimal diet before and after a psychedelic experience.
[5-min read] First-of-its-kind study examines affordability and feasibility in group psilocybin therapy.
[5-min read] Q&A with Ian McCall, Founder & MMA Champion
